Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA.
Ruiz-Bañobre J, Rodriguez-Casanova A, Costa-Fraga N, Bao-Caamano A, Alvarez-Castro A, Carreras-Presas M, Brozos-Vazquez E, Vidal-Insua Y, Vazquez-Rivera F, Candamio-Folgar S, Mosquera-Presedo M, Lago-Lestón RM, Muinelo-Romay L, Vázquez-Bueno JÁ, Sanz-Pamplona R, Moreno V, Goel A, Castillo L, Martin AC, Arroyo R, Esteller M, Crujeiras AB, López-López R, Díaz-Lagares A. Ruiz-Bañobre J, et al. Among authors: vidal insua y. Clin Epigenetics. 2022 Jul 9;14(1):86. doi: 10.1186/s13148-022-01302-x. Clin Epigenetics. 2022. PMID: 35810318 Free PMC article.
Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer.
Rodríguez-Casanova A, Bao-Caamano A, Lago-Lestón RM, Brozos-Vázquez E, Costa-Fraga N, Ferreirós-Vidal I, Abdulkader I, Vidal-Insua Y, Rivera FV, Candamio Folgar S, López-López R, Muinelo-Romay L, Diaz-Lagares A. Rodríguez-Casanova A, et al. Among authors: vidal insua y. J Clin Med. 2021 Sep 29;10(19):4487. doi: 10.3390/jcm10194487. J Clin Med. 2021. PMID: 34640513 Free PMC article.
Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy.
Pérez-Martelo M, González-García A, Vidal-Ínsua Y, Blanco-Freire C, Brozos-Vázquez EM, Abdulkader-Nallib I, Álvarez-Fernández J, Lázare-Iglesias H, García-Martínez C, Betancor YZ, Sánchez-Ares M, Tubío JMC, Vázquez-Rivera F, Candamio-Folgar S, López-López R, Ruiz-Bañobre J. Pérez-Martelo M, et al. Among authors: vidal insua y. Sci Rep. 2022 Apr 27;12(1):6893. doi: 10.1038/s41598-022-10884-8. Sci Rep. 2022. PMID: 35477740 Free PMC article.
[Gum tumor in a patient with background of hepatic cirrhosis].
García-González J, López Rodríguez R, Abdulkader Nallib I, Anido Herranz U, Vidal Insua Y, López López R. García-González J, et al. Among authors: vidal insua y. Rev Clin Esp. 2007 Jul-Aug;207(7):365-6. doi: 10.1157/13107950. Rev Clin Esp. 2007. PMID: 17662203 Spanish. No abstract available.
Dynamic perspective of the neutrophil-to-lymphocyte ratio in metastatic gastric cancer.
Cousillas Castineiras A, Gallardo Martin E, Fernandez Montes A, Carmona Campos M, Covela Rua M, Salgado Fernandez M, Pellon Augusto ML, Martínez Lago N, Vidal Insua Y, Brozos Vazquez E, De La Camara J, Alonso Herrero A, Mendez Mendez JC. Cousillas Castineiras A, et al. Among authors: vidal insua y. J BUON. 2021 Sep-Oct;26(5):2131-2140. J BUON. 2021. PMID: 34761627 Free article.
Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen.
Martínez-Lago N, Cameselle García S, Alonso de Castro B, Gómez-Randulfe Rodríguez MI, Carmona Campos M, González Villarroel P, Salgado Fernández M, De la Cámara Gómez JC, Romero Reinoso C, Cousillas Castiñeiras A, Méndez Méndez JC, Vidal Insua Y, Fernández-Montes A. Martínez-Lago N, et al. Among authors: vidal insua y. PLoS One. 2022 Jun 3;17(6):e0269399. doi: 10.1371/journal.pone.0269399. eCollection 2022. PLoS One. 2022. PMID: 35657983 Free PMC article.
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial.
Quintero Aldana G, Salgado M, Candamio S, Méndez JC, Jorge M, Reboredo M, Vázquez Tuñas L, Romero C, Covela M, Fernández Montes A, Carmona M, Vidal Insua Y, López R; Galician Oncological Research Group (GGIO). Quintero Aldana G, et al. Among authors: vidal insua y. Clin Transl Oncol. 2020 Apr;22(4):495-502. doi: 10.1007/s12094-019-02151-6. Epub 2019 Jul 6. Clin Transl Oncol. 2020. PMID: 31280434 Clinical Trial.